Member zone
  • Follow
  • Follow
  • Home
  • What are vascular liver diseases
  • Who we are
  • Research Projects
    • Rules to be submit a project to VALDIG
    • Projects
    • Rules of publication
  • Become member
  • News-Forum
    • News
    • Forum
  • Education
    • Events
    • Resources
    • IRCPSS – clinical case conferences
  • Database

Reply To: Prophylaxis of SOS in patient with vascular liver disease

Home › Forums › Valdig.eu website › Prophylaxis of SOS in patient with vascular liver disease › Reply To: Prophylaxis of SOS in patient with vascular liver disease

7 May 2021 at 9h21 #2757
Pierre-Emmanuel Rautou
Moderator

Dear Dhiraj,
I completely share what has been said: scarce data but in this specific setting Defibrotide on top of UDCA seems reasonable.
Best wishes
Pierre-Emmanuel

Latest news

  • International Congress on Coagulopathy in Liver Disease
  • PSVD atlas
  • Paris PSVD meeting
  • Save the date // Paris PSVD meeting // Dec 4th & 5th 2025
  • COST action EURO-VALDI-NET // a new call is now open

Latest comments

No comments to show.

Contact

Marco Senzolo
Unit of Vascular liver diseases and treatment of portal hypertension, gastroenterology
University Hospital of Padova, Italy

Endorsed by

Member of

Login

Forgot your password?